1712. Novel Diagnostics: Clinical Applications in Transplantation
Session: Symposium: The Future of Transplant ID: Novel Diagnostics and Therapeutics
Saturday, October 6, 2018: 8:45 AM
Room: S 214-216
Kim Hanson, MD, MHS, University of Utah School of Medicine, Salt Lake City, UT

Dr. Kimberly Hanson is the Director of the Transplant Infectious Diseases and Immunocompromised Host Service at the University of Utah Hospital and Section Chief for Clinical Microbiology within ARUP Laboratories. Her clinical and research interests include the diagnosis and management of transplant related infections and development of novel diagnostic tests for ID.


Disclosures:

K. Hanson, BioFire: Grant Investigator , Research grant .

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.